Elaine Weiner is a Psychiatry physician affiliated with University of Maryland, Baltimore. OpenAlex indexes 33 publications with 1,601 citations (h-index 17); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Spring Grove Hospital Grounds
Maple And Locust Streets
Baltimore, MD 21228
Telephone
410-402-7694Registry record last updated 8 Nov 2011.
Clinical trials
- Comparison of Varenicline and Placebo for Smoking Cessation in Schizophrenia
Sponsor: University of Maryland, Baltimore
- A Comparison of Bupropion SR and Placebo for Smoking Cessation
Sponsor: University of Maryland, Baltimore
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ITI, Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
77.1%Atypical Antipsychotic37.5%Clozapine61%Risperidone13%Olanzapine10%Aripiprazole6%Clozapine Odt4%Quetiapine Fumarate2%Ziprasidone Hcl2%Rexulti2%Part D<11 patientsBenzodiazepine14.9%Lorazepam82%Clonazepam13%Alprazolam6%Part D<11 patients+ 11 more classes in this area
Cardiovascular
11%Beta blocker6.2%Metoprolol Succinate51%Atenolol12%Atenolol-Chlorthalidone12%Metoprolol Tartrate12%Propranolol Hcl12%Part D<11 patientsACE inhibitor3.1%Lisinopril-Hydrochlorothiazide75%Lisinopril25%Part D<11 patients+ 2 more classes in this area
Respiratory
6.8%Anticholinergic6.8%Glycopyrrolate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 25-Hydroxyvitamin D and metabolic-related laboratory values in women with schizophrenia and hyperprolactinemia
Journal of Psychiatric Research
2022 - Combined Oxytocin and Cognitive Behavioral Social Skills Training for Social Function in People With Schizophrenia
Journal of Clinical Psychopharmacology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Kittner
University of Maryland, Baltimore
Edward Sausville, MD
University of Maryland, Baltimore
Aloke Finn, MD
University of Maryland, Baltimore
Christopher Plowe, MD
University of Maryland, Baltimore
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”